These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22990809)

  • 1. Ca(V)1.2 I-II linker structure and Timothy syndrome.
    Almagor L; Chomsky-Hecht O; Ben-Mocha A; Hendin-Barak D; Dascal N; Hirsch JA
    Channels (Austin); 2012; 6(6):468-72. PubMed ID: 22990809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein.
    Cheng EP; Yuan C; Navedo MF; Dixon RE; Nieves-Cintrón M; Scott JD; Santana LF
    Circ Res; 2011 Jul; 109(3):255-61. PubMed ID: 21700933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timothy mutation disrupts the link between activation and inactivation in Ca(V)1.2 protein.
    Depil K; Beyl S; Stary-Weinzinger A; Hohaus A; Timin E; Hering S
    J Biol Chem; 2011 Sep; 286(36):31557-64. PubMed ID: 21685391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated basal transcription can underlie timothy channel association with autism related disorders.
    Servili E; Trus M; Sajman J; Sherman E; Atlas D
    Prog Neurobiol; 2020 Aug; 191():101820. PubMed ID: 32437834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
    Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
    J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8).
    Drum BM; Dixon RE; Yuan C; Cheng EP; Santana LF
    J Mol Cell Cardiol; 2014 Jan; 66():63-71. PubMed ID: 24215710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timothy syndrome iPSC modeling.
    Bekdash R; Klein AD; Yazawa M
    Mol Cell Neurosci; 2020 Sep; 107():103529. PubMed ID: 32629111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome.
    Wemhöner K; Friedrich C; Stallmeyer B; Coffey AJ; Grace A; Zumhagen S; Seebohm G; Ortiz-Bonnin B; Rinné S; Sachse FB; Schulze-Bahr E; Decher N
    J Mol Cell Cardiol; 2015 Mar; 80():186-95. PubMed ID: 25633834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca(2+)-dependent inactivation.
    Dick IE; Joshi-Mukherjee R; Yang W; Yue DT
    Nat Commun; 2016 Jan; 7():10370. PubMed ID: 26822303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.
    Han D; Xue X; Yan Y; Li G
    Exp Biol Med (Maywood); 2019 Sep; 244(12):960-971. PubMed ID: 31324123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
    Landstrom AP; Boczek NJ; Ye D; Miyake CY; De la Uz CM; Allen HD; Ackerman MJ; Kim JJ
    Int J Cardiol; 2016 Oct; 220():290-8. PubMed ID: 27390944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
    Yazawa M; Hsueh B; Jia X; Pasca AM; Bernstein JA; Hallmayer J; Dolmetsch RE
    Nature; 2011 Mar; 471(7337):230-4. PubMed ID: 21307850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium Channel Mutations in Cardiac Arrhythmia Syndromes.
    Betzenhauser MJ; Pitt GS; Antzelevitch C
    Curr Mol Pharmacol; 2015; 8(2):133-42. PubMed ID: 25981977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Timothy syndrome with iPS cells.
    Yazawa M; Dolmetsch RE
    J Cardiovasc Transl Res; 2013 Feb; 6(1):1-9. PubMed ID: 23299782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome.
    Marcantoni A; Calorio C; Hidisoglu E; Chiantia G; Carbone E
    Pflugers Arch; 2020 Jul; 472(7):775-789. PubMed ID: 32621084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction into Ca(v)2.1 of the homologous mutation of Ca(v)1.2 causing the Timothy syndrome questions the role of V421 in the phenotypic definition of P-type Ca(2+) channel.
    Cens T; Leyris JP; Charnet P
    Pflugers Arch; 2008 Nov; 457(2):417-30. PubMed ID: 18536931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca²⁺ channels revealed by Timothy syndrome mutation.
    Sheng X; Nakada T; Kobayashi M; Kashihara T; Shibazaki T; Horiuchi-Hirose M; Gomi S; Hirose M; Aoyama T; Yamada M
    Eur J Pharmacol; 2012 Jun; 685(1-3):15-23. PubMed ID: 22554770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Cav1.2 function in the Timothy syndrome mouse model produces ascending serotonergic abnormalities.
    Ehlinger DG; Commons KG
    Eur J Neurosci; 2017 Oct; 46(8):2416-2425. PubMed ID: 28921675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-type Ca2+ channel function during Timothy syndrome.
    Dixon RE; Cheng EP; Mercado JL; Santana LF
    Trends Cardiovasc Med; 2012 Apr; 22(3):72-6. PubMed ID: 22999068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swapping the I-II intracellular linker between L-type CaV1.2 and R-type CaV2.3 high-voltage gated calcium channels exchanges activation attributes.
    Gonzalez-Gutierrez G; Miranda-Laferte E; Contreras G; Neely A; Hidalgo P
    Channels (Austin); 2010; 4(1):42-50. PubMed ID: 20026913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.